Hims & Hers Health, Inc.HIMSNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR+42.9%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
+42.9%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202589.42%
202463.43%
202364.95%
202230.64%
202199.14%
20200.00%
20190.00%